| Hereditary hemochromatosis—a new look at an old disease A Pietrangelo New England Journal of Medicine 350 (23), 2383-2397, 2004 | 1306 | 2004 |
| Tocilizumab in patients with severe COVID-19: a retrospective cohort study G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ... The Lancet Rheumatology 2 (8), e474-e484, 2020 | 1060 | 2020 |
| BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism B Andriopoulos Jr, E Corradini, Y Xia, SA Faasse, S Chen, L Grgurevic, ... Nature genetics 41 (4), 482-487, 2009 | 957 | 2009 |
| Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia S De Biasi, M Meschiari, L Gibellini, C Bellinazzi, R Borella, L Fidanza, ... Nature communications 11 (1), 3434, 2020 | 793 | 2020 |
| Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment A Pietrangelo Gastroenterology 139 (2), 393-408. e2, 2010 | 746 | 2010 |
| Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene G Montosi, A Donovan, A Totaro, C Garuti, E Pignatti, S Cassanelli, ... The Journal of clinical investigation 108 (4), 619-623, 2001 | 694 | 2001 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 584 | 2003 |
| EASL clinical practice guidelines for HFE hemochromatosis European Association For The Study Of The Liver Journal of hepatology 53 (1), 3-22, 2010 | 522 | 2010 |
| The ferroportin disease A Pietrangelo Blood Cells, Molecules, and Diseases 32 (1), 131-138, 2004 | 482 | 2004 |
| ER stress controls iron metabolism through induction of hepcidin C Vecchi, G Montosi, K Zhang, I Lamberti, SA Duncan, RJ Kaufman, ... Science 325 (5942), 877-880, 2009 | 389 | 2009 |
| Haemochromatosis P Brissot, A Pietrangelo, PC Adams, B De Graaff, CE McLaren, O Loréal Nature reviews Disease primers 4 (1), 1-15, 2018 | 386 | 2018 |
| STAT3 is required for IL-6-gp130–dependent activation of hepcidin in vivo A Pietrangelo, U Dierssen, L Valli, C Garuti, A Rump, E Corradini, M Ernst, ... Gastroenterology 132 (1), 294-300, 2007 | 386 | 2007 |
| Iron regulatory proteins in pathobiology G CAIRO, A Pietrangelo Biochemical Journal 352 (2), 241-250, 2000 | 385 | 2000 |
| Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload H Zoller, G Weiss, I Theurl, RO Koch, W Vogel, P Obrist, A Pietrangelo, ... Gastroenterology 120 (6), 1412-1419, 2001 | 376 | 2001 |
| Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene A Pietrangelo, G Montosi, A Totaro, C Garuti, D Conte, S Cassanelli, ... New England Journal of Medicine 341 (10), 725-732, 1999 | 345 | 1999 |
| Hepatitis C virus–induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription S Nishina, K Hino, M Korenaga, C Vecchi, A Pietrangelo, Y Mizukami, ... Gastroenterology 134 (1), 226-238, 2008 | 312 | 2008 |
| Heterogeneity of hemochromatosis in Italy A Piperno, M Sampietro, A Pietrangelo, C Arosio, L Lupica, G Montosi, ... Gastroenterology 114 (5), 996-1002, 1998 | 294 | 1998 |
| Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells P Schirmacher, A Geerts, A Pietrangelo, HP Dienes, CE Rogler Hepatology 15 (1), 5-11, 1992 | 292 | 1992 |
| Non‐HFE hemochromatosis A Pietrangelo Hepatology 39 (1), 21-29, 2004 | 259 | 2004 |
| Hereditary hemochromatosis A Pietrangelo Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1763 (7), 700-710, 2006 | 256 | 2006 |
